Literature DB >> 28820750

The New Realization About Cribriform Prostate Cancer.

Kenneth A Iczkowski1, Gladell P Paner2, Theodorus Van der Kwast3.   

Abstract

Data from the past 6 years have shown that the presence of any amount of cribriform (or more comprehensively, large acinar cribriform to papillary) pattern of invasive prostate cancer is associated with adverse pathologic features and leads to uniquely adverse outcomes. Sixteen papers and numerous abstracts have reached these conclusions concordantly. Not only does this justify removal of all cribriform cancer from Gleason grade 3, it shows that cribriform cancer has pathologic, outcome, and molecular features distinct from noncribriform Gleason grade 4. Suggestions for accommodating the presence of cribriform cancer into the 2014 Grade Group scheme are proposed.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28820750     DOI: 10.1097/PAP.0000000000000168

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  10 in total

1.  Syntaphilin Is a Novel Biphasic Biomarker of Aggressive Prostate Cancer and a Metastasis Predictor.

Authors:  Michael J Hwang; Kelly G Bryant; Jae H Seo; Qin Liu; Peter A Humphrey; Mary Ann C Melnick; Dario C Altieri; Marie E Robert
Journal:  Am J Pathol       Date:  2019-05-09       Impact factor: 4.307

2.  Histopathological Study of the Prostate Cancer Growth Patterns in Relation with the Grading Systems.

Authors:  Tudor Cristian Timotei Popescu; Alex Emilian Stepan; Mirela Marinela Florescu; Cristiana Eugenia Simionescu
Journal:  Curr Health Sci J       Date:  2022-03-31

3.  Computationally Derived Cribriform Area Index from Prostate Cancer Hematoxylin and Eosin Images Is Associated with Biochemical Recurrence Following Radical Prostatectomy and Is Most Prognostic in Gleason Grade Group 2.

Authors:  Patrick Leo; Sacheth Chandramouli; Xavier Farré; Robin Elliott; Andrew Janowczyk; Kaustav Bera; Pingfu Fu; Nafiseh Janaki; Ayah El-Fahmawi; Mohammed Shahait; Jessica Kim; David Lee; Kosj Yamoah; Timothy R Rebbeck; Francesca Khani; Brian D Robinson; Natalie N C Shih; Michael Feldman; Sanjay Gupta; Jesse McKenney; Priti Lal; Anant Madabhushi
Journal:  Eur Urol Focus       Date:  2021-04-30

Review 4.  Intraductal Carcinoma of the Prostate as a Cause of Prostate Cancer Metastasis: A Molecular Portrait.

Authors:  Helen Pantazopoulos; Mame-Kany Diop; Andrée-Anne Grosset; Frédérique Rouleau-Gagné; Afnan Al-Saleh; Teodora Boblea; Dominique Trudel
Journal:  Cancers (Basel)       Date:  2022-02-06       Impact factor: 6.639

5.  Diffusion Restriction Comparison between Gleason 4 Fused Glands and Cribriform Glands within Patient Using Whole-Mount Prostate Pathology as Ground Truth.

Authors:  Savannah R Duenweg; Xi Fang; Samuel A Bobholz; Allison K Lowman; Michael Brehler; Fitzgerald Kyereme; Kenneth A Iczkowski; Kenneth M Jacobsohn; Anjishnu Banerjee; Peter S LaViolette
Journal:  Tomography       Date:  2022-03-02

6.  Large and small cribriform architecture have similar adverse clinical outcome on prostate cancer biopsies.

Authors:  L Lucia Rijstenberg; Tim Hansum; Charlotte F Kweldam; Intan P Kümmerlin; Sebastiaan Remmers; Monique J Roobol; Geert J L H van Leenders
Journal:  Histopathology       Date:  2022-05-04       Impact factor: 7.778

7.  The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma.

Authors:  Geert J L H van Leenders; Theodorus H van der Kwast; David J Grignon; Andrew J Evans; Glen Kristiansen; Charlotte F Kweldam; Geert Litjens; Jesse K McKenney; Jonathan Melamed; Nicholas Mottet; Gladell P Paner; Hemamali Samaratunga; Ivo G Schoots; Jeffry P Simko; Toyonori Tsuzuki; Murali Varma; Anne Y Warren; Thomas M Wheeler; Sean R Williamson; Kenneth A Iczkowski
Journal:  Am J Surg Pathol       Date:  2020-08       Impact factor: 6.298

8.  The validation of the 2014 International Society of Urological Pathology (ISUP) grading system for patients with high-risk prostate cancer: a single-center retrospective study.

Authors:  Jiandong Liu; Jinge Zhao; Mengni Zhang; Ni Chen; Guangxi Sun; Yaojing Yang; Xingming Zhang; Junru Chen; Pengfei Shen; Ming Shi; Hao Zeng
Journal:  Cancer Manag Res       Date:  2019-07-12       Impact factor: 3.989

9.  Clinical outcome comparison of Grade Group 1 and Grade Group 2 prostate cancer with and without cribriform architecture at the time of radical prostatectomy.

Authors:  Eva Hollemans; Esther I Verhoef; Chris H Bangma; John Rietbergen; Monique J Roobol; Jozien Helleman; Geert J L H van Leenders
Journal:  Histopathology       Date:  2020-04       Impact factor: 5.087

10.  Comedonecrosis Gleason pattern 5 is associated with worse clinical outcome in operated prostate cancer patients.

Authors:  Tim Hansum; Eva Hollemans; Esther I Verhoef; Chris H Bangma; John Rietbergen; Susanne Osanto; Rob C M Pelger; Tom van Wezel; Henk van der Poel; Elise Bekers; Jozien Helleman; Sebastiaan Remmers; Geert J L H van Leenders
Journal:  Mod Pathol       Date:  2021-06-26       Impact factor: 7.842

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.